Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.

#SenjuPharma has launched a new drug for #dryeyedisease (DED) in #Japan, #Avarept, which is the first drug in the #TRPV1antagonist class to reach the market.